Merck has been asked to retest their new drug after it has been approved by thee FDA. The FDA will sometimes decide to retest drugs if reports have come in about side effects not known about in the original testing. Companies may be fined up to $250,000 if they do not comply to retest their drug. The new drug on the market from Merck has been reported to cause pancreas inflammation. Not many companies refuse to do this but there are some that do. Refusing to retest drugs not only result in a in a fine, but it can result in people dying from diseases contracted or side effects to the drug.
~Stephanie
No comments:
Post a Comment